← Leaderboards
Aileen Estelle Baldwin
U.S. Drug Testing Laboratories, Inc.
$1,053,569
Attributed
$1,053,569
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.6K · FY2013–21$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,053,569 · 3
By mechanism
R44$640,354 · 1
R43$413,215 · 2
Top collaborators
No co-investigators on record.
Most similar at U.S. Drug Testing Laboratories, Inc.
Same institution · by research overlap
- Charles A Plate$2,694,205
Others in their field
Top investigators on “Medical Specialties”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$105,784,300
- Judith S. Currier · University Of California Los Angeles$104,043,035
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$88,477,974
- Jonathan S Lewin · Case Western Reserve University$69,726,154
- Elizabeth A Thom · George Washington University$56,281,643
- Polly Chang · Sri International$55,780,388
Research focus
Medical SpecialtiesFetalGenetic ScreeningLaboratoriesEpigenetic MarkerEpigenetic ProcessEarly InterventionFetal Drug ExposureDiagnosisIn UteroDna MethylationBehavioralAlcohol ExposureBiological MarkersAlcoholsDrug TestingBirthEmbryonic DevelopmentBloodAffectDevelopmental DisabilitiesIncidenceChildMethylation
Grant awards (4)
Identification of Epigenetic Biomarkers Associated with Prenatal Exposure to Substances of Abuse$250,900
R43 · FY2021 · DA · contact PI
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorders$202,718
R44 · FY2018 · AA · contact PI
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorders$437,636
R44 · FY2017 · AA · contact PI
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum D$162,315
R43 · FY2013 · AA · contact PI